At the 2010 BIO Conference in Chicago with about 15,000 attendees there were ten Breakout Sessions on Biomarkers (BM) encompassing Intellectual Property, commercialization, reimbursement, drug ...

The landscape of dementia diagnostics is undergoing a paradigm shift with the emergence of liquid biopsy, blood-based biomarkers (BBMs), and blood-derived ...

NEW YORK, NY; NEW HAVEN, CT; and PRINCETON, NJ, March 10, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ('Aptorum Group” or ...

An international group of clinicians and researchers have agreed that Alzheimer’s disease blood biomarkers (BBMs) are a significant breakthrough, but are not yet ready for general clinical and primary ...

Over 22 million Americans are diagnosed with ADHD -- yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive(1) Firefly's AI-powered ...

ExosomeDx, together with its parent company Bio-Techne, combines expertise in exosome technologies with experience in the non-invasive liquid biopsy market to create solutions for companion diagnostic ...

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Please provide your email address to receive an email when new articles are posted on . Labcorp and Quest Diagnostics have both announced the availability of blood-based biomarker testing for ...

Our increasing knowledge of the complex nature of molecular interactions has enabled us to not only understand physiological and pathological processes better but also to identify biological markers ...

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the Presage® ST2 Assay and ASPECT-PLUS TM ST2 Test, both used to help physicians in the management of heart failure patients, today ...

Derived from early pandemic waves and needing recalibration for new variants, these renal markers and IL 10 could act as ...

Next-generation biomarker discovery and diagnostics Bio-Techne combines expertise in exosome technologies with experience in the non-invasive liquid biopsy market to create solutions for companion ...